Clinical & translational oncology

• 

  Año 2026, Vol. 28, Número 8

  • REVIEW ARTICLE

    • Genomic alterations and their correlation with metabolic-related genes in lung cancer

      Gauri Gaur, Niraj Kumar Jha, Lokesh Gambhir, Seema V. Acharya, Dhruv Kumar

      • Resumen

      págs. 2975-2992

      

    • Role of cytoreductive surgery in the management of peritoneal metastases for gastrointestinal stromal tumors

      Irene López Rojo, Paula Muñoz Muñoz, Luis González Bayón, F.C. Muñoz Casares, César Serrano, Juan Ángel Fernández Hernández, Pere Bretcha Boix, Santiago González Moreno, José Manuel Asencio Pascual

      • Resumen

      págs. 2993-3004

      

    • Research progress of machine learning applications in gastric cancer diagnosis and therapy

      Wen Zhuo Cui, Cheng Quan Wen, Chao Qun Li, Qiu Jie Zhang, Qing Qing Yu, Wei Wei Sun

      • Resumen

      págs. 3005-3019

      

    • Iron, inflammation, and intestinal tumors: the crucial triad in colorectal cancer progression and therapy

      Mona Abediasl, Mehrnoush Siavash, Sina Sagharizadeh Esfahani, Zahra Amini, Koosha Amiri, Sadaf Saket, Elham Esmaeili, Fatemeh Rafizadeh, Roya Saraei, Masoud Saadat Fakhr

      • Resumen

      págs. 3020-3041

      

    • Unravelling the pathogenesis and therapeutic approaches of pancreatic ductal adenocarcinoma

      Isha Roy, Raman Thakur

      • Resumen

      págs. 3042-3058

      

    • Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approaches

      Carmen Beato Zambrano, Xavier Nogués Solán, Natalia Ramírez Merino, Soledad Librizzi, Santos Castañeda Sanz, Iñigo Etxebarria Foronda, F. Henao Carrasco, Javier Puente Vázquez, Ibon Gurruchaga Sotés, Guillermo Martínez Díaz Guerra

      • Resumen

      págs. 3059-3074

      

    • Genotoxicity of cancer therapies and the risk of secondary malignancies: toward personalized prevention

      Olorunfemi Raphael Molehin, Amos Tomiwa Afolabi

      • Resumen

      págs. 3075-3085

      

    • Epithelial–mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities

      Dhiraj Kumar Singh, Rashmi Gupta, Umesh Kumar, Saurabh Gupta

      • Resumen

      págs. 3086-3091

      

    • Planning and deploying a remote satellite radiotherapy unit: a practical guide for clinicians and health administrators

      E. Mª. Corrales García, P. D. Delgado López, Jerónimo González Bernal

      • Resumen

      págs. 3092-3102

      

  • RESEARCH ARTICLE

    • Compatibility of different PET/CT criteria in evaluating treatment response and survival in non-small cell lung cancer patients treated with immunotherapy

      İmdat Eroğlu, Uğuray Aydos, Yasemin Ünlüer Ateş, Selahattin Barış Küçükali, Orhun Akdoğan, Aytuğ Üner, Fatih Gürler, Nuriye Özdemir, Ahmet Özet, Ozan Yazici

      • Resumen

      págs. 3103-3112

      

    • A Decadal Bibliometric Analysis of Circulating Tumor DNA (ctDNA) Research in Lung Cancer (2012-2022)

      Xiaofang Zhang, Junjun Bai

      • Resumen

      págs. 3113-3122

      

    • Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer

      Yu Wang, Yi Tong Li, Ming Hao Wang, Cheng Yi Zhang, Ying Jiang, Qi Xu, Ying Ping Liu, Can Jun Li, Ye Xiong Li, Nan Bi

      • Resumen

      págs. 3123-3135

      

    • Therapeutic strategies for elderly patients with unresectable limited-stage small cell lung cancer

      Rui Zhou, Wen-zhu Li, Yue Cong, Ling-cui Meng, Yan-hui Jiang, Li-ting Fang, Xin Qu

      • Resumen

      págs. 3136-3146

      

    • Single-cell and bulk transcriptomic profiling of metabolism-related lncRNAs reveals tumor heterogeneity and prognostic markers in non-small cell lung cancer

      Bin Zhou, Xuelong Wang, Liwei Su, Yanchao Liu, Mengxu Zhu, Xianchao Guo, Chengwei Zhang

      • Resumen

      págs. 3147-3159

      

    • Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group

      Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu, Hayati Arvas, Harun Muglu, Ahmet Bilici, Mustafa Seyyar, Halil Göksel Güzel, Banu Öztürk, Ozge Yalıcı, Duygu Ozaskın, Ramazan Cosar, Fatmagul Cıkladılmez, Evrican Zin, Aytac Terzi, Tugce Ulaslı, Taha Koray Sahın, Denız Can Guven, Gamze Serın, Merve Bıyıklı Alemdar, Bilgin Demir, Ali Kalem, Pervin Can, Kazım Uygun, Erdem Goker

      • Resumen

      págs. 3160-3169

      

    • Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictors

      Jiaheng Zhang, Keyue Qiu, Hang Chen, Zeyang Hu, Hongxiang Li, Zijun Xie, Guodong Xu

      • Resumen

      págs. 3170-3179

      

    • Time- and dose-dependent regulation of circular RNAs in the response of triple-negative breast cancer cells to ionizing radiation

      Maria Papatsirou, Eleni Mavrogonatou, Dimitris Kletsas, Andreas Scorilas, Christos K. Kontos

      • Resumen

      págs. 3180-3192

      

    • An interpretable breast cancer risk stratification model via multi-omics integration: multi-method development and cross-cohort validation

      Weirong Xue, Xiaoxiao Zhu, Guangshuang Zhou, Changqing Xu, Yi Sun, Yingliang Jin

      • Resumen

      págs. 3193-3205

      

    • Multigene panel testing reveals the spectrum of non-BRCA germline variants in BRCA1/2-negative breast, ovarian, and prostate cancer patients from a Turkish cohort

      Barıs Paksoy, Ozgur Erkal, Ayca Kocaaga

      • Resumen

      págs. 3206-3215

      

    • 3216-3227

      Man Yu, Pei Wang, Rui Liu, Yu-Min Li

      • Resumen

      págs. 3216-3227

      

    • Establishment of insulin resistance-related ten-gene signature in endometrial cancer and identification of ACTL8 as a prognostic and immunological biomarker

      Siyun Lu, Jie Xu, XiaoXiao Sun, Jie Yuan, Jiajing Cheng, Jinlong Qin

      • Resumen

      págs. 3228-3243

      

    • Evaluation of serum Cytokeratin 5 and p63 as non-invasive biomarkers for the diagnosis and staging of cervical cancer: a case–control study

      Redha Dawud Abd Alredha, Thulfiqar Noor Hussein, Hussein Sattar Rebat Alzerfi, Krarr Haider Haddawi

      • Resumen

      págs. 3244-3252

      

    • Unraveling CD4+ T cell heterogeneity and cell death-associated genes in high-grade serous ovarian cancer: a comprehensive analysis of single-cell RNA and spatial transcriptome sequencing

      Shaobo Wu, Chunfeng Wu, Jiayi Yu, Yaoyao Li, Yanhong Lv, Lei Ding, Di Zhang, Yurou Zhou, Jun Tang

      • Resumen

      págs. 3253-3276

      

    • Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain

      Sigfredo Elias Romero Zoghbi, F. López Campos, Abrahams Ocanto, David Sanz Rosa, Israel John Thuissard Vasallo, Cristina Andreu Vázquez, Cristina Laria, Jaime Fernández-Ibiza, Jon Andreescu, Evita Krumina, María Mateos, Maia Dzhugashvili, Luis Alberto Glaría Enríquez, Daniela Gonsalves, Castalia Fernández, David Esteban, José Begara de la Fuente, José Antonio González Ferreira, Antonio Ristori, Daniel Rivas, Escarlata López, Ana Belén Bezares Alarcón, Loubna Aakki, Luis Larrea, Felipe Couñago Lorenzo

      • Resumen

      págs. 3277-3286

      

    • Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study

      Javier Puente Vázquez, Ruben Campanario Pérez, David Marmolejo, Juan Andrés Cantero Mellado, Álvaro Gómez Ferrer, Alfredo Rodríguez Antolín, Natalia Picola Brau, María José Ledo Cepero, Carlos Hernández, Carlos Llorente Abarca, Carmen González Enguita, Álvaro Bisonó Castillo, Joan Maria Benejam Gual, Jesús Gil Guijarro, José García Sánchez, Joan Folqué, Javier Casas Nebra, María José Ribal Caparrós

      • Resumen

      págs. 3287-3295

      

    • Salvage radiotherapy after cryotherapy in prostate cancer

      F. León, S. Moreno López, J. Mases, Elías Gomis Sellés, G. Meca, Izaskun Valduvieco Ruiz, G. Oses, G. Antelo, Francesc Casas, C. Clavell, P. Navarro, L. Delgado, María José Ribal Caparrós, M. Mollà

      • Resumen

      págs. 3296-3303

      

    • Neutrophil-to-lymphocyte ratio in unresectable or metastatic esophageal squamous cell carcinoma: a systematic review, meta-analysis and meta-regression

      Giuseppe Antonio Colloca, Antonella Venturino

      • Resumen

      págs. 3304-3312

      

    • Characteristics and prognosis according to tumor location in esophageal squamous cell carcinoma

      Dae Gon Ryu, Cheol Woong Choi, Su Jin Kim, Su Bum Park, Jin Ook Jang, Woo Jin Kim, Bong Soo Son

      • Resumen

      págs. 3313-3320

      

    • ANKRD1 expression and functional mechanism in stomach adenocarcinoma

      Lu Nie, Yu Nie, Ruiyang Wang

      • Resumen

      págs. 3321-3336

      

    • Prognostic value of the lactate-based modified cally score in postoperative gastric cancer patients admitted to the ICU

      Öztürk Taşkın, Veysel Garani Soylu, Ufuk Demir, Ayşe Yılmaz, Büşra Tanyıldızı Küçük

      • Resumen

      págs. 3337-3344